Coronavirus (COVID-19) Updates
WVCI – Cancer Center Eugene, Corvallis, Florence Oregon
  • Languages
  • Careers
  • Patient forms
  • Bill pay
  • Patient portal
    Menu
    • FOR PATIENTS
      • blank
        • Appointments
        • Support services
        • CaringBridge
        • Integrative care
        • Nutrition Counseling Services
        • Oncology social services
        • Patient navigator
      • blank
        • FAQs
        • Feedback survey
        • Insurance and payments
          • Bill pay
          • Financial records
        • Laboratory
      • blank
        • Patient advocacy
        • Patient forms
        • Patient portal
        • Pharmacy
        • Your First Oncology Visit
          • What to ask
      • blank
        • Second opinions and referrals
        • Support groups
        • Traveling patients
        • When to see your primary care provider
    • PROVIDERS & STAFF
      • Providers
      • Managers
      • Support Services Team
    • CANCERS & TREATMENT
      • Cancer Treatments
        • Chemotherapy
        • Clinical Trials
        • Radiation Therapy
        • Hormone Therapy
        • Immunotherapy
        • Targeted Therapy
      • Cancers We Treat
        • Breast Cancer
        • Colon and Rectal Cancers
        • Gynecologic Cancers
        • Leukemia
        • Lung Cancers
        • Lymphomas
      • blank
        • Melanoma
        • Multiple Myeloma
        • Pancreatic Cancer
        • Prostate Cancer
        • Skin Cancers
        • View All Cancer Types
    • CLINICAL TRIALS
      • Available clinical trials
      • Clinical trials FAQ
    • BLOG
    • LOCATIONS
    • CONTACT
    • FOR PATIENTS
      • Overview
      • Appointments
      • Support services
      • CaringBridge
      • Integrative care
      • Nutrition Counseling Services
      • Oncology social services
      • Patient navigator
      • FAQs
      • Feedback survey
      • Insurance and payments
        • Bill pay
        • Financial records
      • Laboratory
      • Patient advocacy
      • Patient forms
      • Patient portal
      • Pharmacy
      • Your First Oncology Visit
        • What to ask
      • Second opinions and referrals
      • Support groups
      • Traveling patients
      • When to see your primary care provider
    • PROVIDERS & STAFF
      • Providers
      • Managers
      • Support Services Team
    • CANCERS & TREATMENT
      • Overview
      • Radiation Therapies
      • Bladder cancer
        • Bladder cancer diagnosis
        • Bladder cancer staging
        • Bladder cancer treatment options
      • Blood cancers
      • Breast cancer
      • Central nervous system tumors
        • CNS tumor diagnosis
        • CNS tumor types, grades
        • CNS tumor treatment
      • Cervical cancer
        • Cervical cancer diagnosis
        • Cervical cancer staging
        • Cervical cancer treatment options
      • Colon and rectal cancer
        • Colon and rectal cancer diagnosis
        • Colon and rectal cancer staging
        • Colon and rectal cancer treatment options
      • Endometrial cancer
        • Endometrial cancer diagnosis
        • Endometrial cancer staging
        • Endometrial cancer treatment options
      • Head and neck cancers
      • Hodgkin’s lymphoma
      • Gynecologic Cancers
      • Kidney cancer
      • Leukemia
        • Learn about leukemia
        • Leukemia types
        • Leukemia diagnosis
        • Leukemia treatment options
      • Liver cancer
      • Lung cancer
        • Non-small cell lung cancer
        • Small cell lung cancer
      • Melanoma
      • Mesothelioma
        • Mesothelioma detection and diagnosis
        • Mesothelioma staging
        • Mesothelioma treatment options
      • Multiple myeloma
      • Myelodysplastic syndromes
      • Non-Hodgkin’s lymphoma
      • Oral cancer
      • Ovarian cancer
        • Ovarian cancer diagnosis
        • Ovarian cancer staging
        • Ovarian cancer treatment options
      • Pancreatic cancer
        • Pancreatic cancer diagnosis
        • Pancreatic cancer staging
        • Pancreatic cancer treatment options
      • Prostate cancer
        • Prostate cancer testing & diagnosis
        • Prostate cancer staging
        • Prostate cancer treatment options
      • Sarcoma
        • Sarcoma diagnosis
        • Sarcoma staging
        • Sarcoma treatment options
      • Skin cancer
        • Skin cancer diagnosis
        • Skin cancer staging
        • Skin cancer treatment options
      • Thyroid cancer
        • Thyroid cancer diagnosis
        • Thyroid cancer staging
        • Thyroid cancer treatment options
    • CLINICAL TRIALS
      • Clinical trials and research
      • Available clinical trials
      • Clinical trials FAQ
    • BLOG
    • LOCATIONS
    • CONTACT
      Previous next
      New lung cancer therapies inspire hope at summit

      New lung cancer therapies inspire hope at summit

      Anne2-300

      Anne with Chris Draft, former NFL player and founder of the Chris Draft Family Foundation

      There’s a saying in the lung cancer community: If you have lungs, you can get lung cancer.

      It happened to Anne Gallagher, a patient navigator at Willamette Valley Cancer Institute, and according to the American Lung Association, there are more than 400,000 Americans living today who have been diagnosed with lung cancer.

      But there is hope, says Anne, who recently returned from this year’s LUNGevity Hope Summit in Arlington, Virginia.

      The national gathering, which is held each year in May—Lung Cancer HOPE Month—provides support for survivors, caregivers and advocates and is an opportunity to give voice to their experiences. It’s also a chance for survivors to engage in educational sessions on topics like research, immunotherapy, living with lung cancer, nutrition, and becoming an empowered advocate.

      Anne with Chris Draft, former NFL player and founder of the Chris Draft Family Foundation

      “Five years ago, I attended my first Hope Summit and there were 40 people there,” Anne says. “This year, there were around 300.”

      Growing attendance at the Hope Summit is a testament to the fact that more people diagnosed with lung cancer are living longer as a result of breakthroughs in treatment. And the speed at which scientists and researchers are beginning to understand this disease continues to accelerate.

      To put it into perspective: In 2006, just one drug received FDA approval for the treatment of lung cancer. In 2015, six drugs were approved.

      “They are starting to identify the mutations behind lung cancer and they’re developing drugs to target those mutations,” Anne says.

      With better prognosis comes a greater need for resources to help lung cancer patients maintain and improve their quality of life—a topic that’s important to Anne, both as a survivor and as an advocate for patients at WVCI.

      During the Hope Summit, Anne led breakout sessions with attendees, sharing what she has learned in her 14 years of survivorship, and offered information to help them navigate their journey.

      “I tell patients to be proactive and ask for what you want,” Anne says. “Many of these patients are going to be living with lung cancer as a chronic illness. So, how do you manage your life and having cancer? The time they spend in the clinic may be a couple of days a month, but the rest of their time is spent outside the clinic.”

      Summit2-300

      Approx. 300 lung cancer survivors, caregivers and advocates attended Hope Summit 2016

      Approx. 300 lung cancer survivors, caregivers and advocates attended Hope Summit 2016

      As a patient navigator, Anne helps patients connect with resources, like LUNGevity’s LifeLine program, which pairs lung cancer survivors with those newly diagnosed, and the Clinical Trials Ambassadors program, which makes it possible for people who have participated in a lung cancer clinical trial to offer encouragement to patients who are considering enrolling in a study.

      Being an advocate in the lung cancer community and participating in the annual Hope Summit is one more way that Anne can share information with those who need it.

      “I’m able to bring that knowledge back to WVCI, where we offer great resources and where we’re seeing advancements of the science behind the disease. Knowing that, I can go into a room and tell a patient there really is hope.”

      By Willamette Valley Cancer Institute | May 18th, 2016 | Lung Cancer, Inside WVCI

      Share This Page, Choose Your Platform:

      Facebook Twitter LinkedIn Reddit Tumblr Google+ Pinterest Vk Email

      Blog Categories

      • -Coronavirus (COVID-19) (3)
      • Breast Cancer (16)
      • Cancer News (4)
      • Clinical Research (3)
      • Clinical Trials (5)
      • Colon and Rectal Cancer (2)
      • GYN Cancers (3)
      • Inside WVCI (27)
      • Lung Cancer (5)
      • Melanoma (5)
      • Oregon Cancer Alliance (2)
      • Oregon Cancer Foundation (14)
      • Patient Stories (24)
      • Prevention (1)
      • Prostate Cancer (5)
      • Targeting Cancer (74)
      see all topics
      Eugene/Florence: 541-683-5001  •  Corvallis: 541-754-1256
      Facebook Youtube Email
      • For Patients
        • Overview
        • Appointments
        • Comprehensive care
        • FAQs
        • Feedback survey
        • Insurance and payments
        • Laboratory
        • Patient advocacy
        • Patient forms
        • Patient portal
        • Pharmacy
        • Preparing for your first visit
        • Resources
        • Second opinions and referrals
        • Support groups
        • Traveling patients
        • When to see your primary care provider
      US Oncology
      • UNITED TO REDEFINE
        • Breast Cancer
        • Clinical Trials
        • Colorectal Cancer
        • GYN Cancers
        • Leukemia/Lymphoma
        • Lung Cancer
        • Prostate Cancer
      WVCI_logo_footer
      © Willamette Valley Cancer Institute 520 Country Club Road, Eugene, Oregon 97401 | All rights reserved | Privacy Policy | Notice of Privacy Practices | Nondiscrimination Policy